To better explore the clinical role of EDNRA in gastric cancer, we performed the immunohistochemistry experiment validation and relevant clinical cohorts analysis, which revealed that EDNRA expression in gastric cancer tissues is lower than that in adjacent normal tissues and that the high expression of EDNRA indicates with worse prognosis in patients. The gene discussed is EDNRA; the disease is gastric cancer.